Dermatology News

Dermatology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Padovese V et al. - Many atypical and severe presentations were seen, and a poor response to first-line antileishmanial drugs was observed. Resistance to antimonials is of concern and cost-effective therapeutic schemes need to be developed. The cost-effectiveness of pentamidine isethionate has to be determined in a larger population.

Related Articles

Protein-energy malnutrition as a risk factor for visceral leishmaniasis: a review
Parasite Immunology, 10/26/09    Relevance Score: 85%

Determinants of bednet ownership and use in visceral leishmaniasis-endemic areas of the Indian subcontinent
Tropical Medicine & International Health, 11/17/09    Relevance Score: 84%

Diffuse (anergic) cutaneous leishmaniasis responding to amphotericin B
Clinical and Experimental Dermatology, 11/17/09    Relevance Score: 84%

Leishmaniasis presenting to the otolaryngologist: a rare but important cause of persistent hoarseness
The Journal of Laryngology & Otology, 10/08/09    Relevance Score: 83%

Foxp3 expression in lesions of the different clinical forms of American tegumentary leishmaniasis
Parasite Immunology, 10/27/09    Relevance Score: 82%

Today in Derm Infectious Disease...keeping you current

Staphylococcal Toxic Shock Syndrome Erythroderma Is Associated with Superantigenicity and Hypersensitivity
Clinical Infectious Diseases, 12/07/09

Tinea incognito in children: 54 cases
Mycoses, 12/07/09

Silver enhances the in vitro antifungal activity of the saponin, CAY-1
Mycoses, 12/07/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address